Johnson & Johnson Innovative Medicine and Trial Library have expanded a partnership to integrate the latter's clinical trial discovery platform into the pharma’s oncology clinical development and medical affairs programs. In a March 21 press release about the development, Trial Library CEO and founder Hala Borno, M.D., said the company is “delighted” to continue working with Johnson & Johnson to “change the standard practice for recruiting diverse populations to clinical trials.”
